Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-15 Sale |
2023-05-17 4:51 pm |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
1,311 | $83.59 | $109,589 | 46,781 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 4:39 pm |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President |
22,132 | $84.45 | $1,869,150 | 116,172 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 4:34 pm |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer |
6,233 | $84.56 | $527,063 | 78,373 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 4:29 pm |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
640 | $83.15 | $53,214 | 39,491 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 4:26 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
1,086 | $85.37 | $92,714 | 25,679 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 4:21 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
1,311 | $83.77 | $109,829 | 30,885 (Direct) |
View |
| 2023-05-12 Sale |
2023-05-16 4:17 pm |
REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs |
7,166 | $86.01 | $616,352 | 31,591 (Direct) |
View |
| 2023-03-13 Sale |
2023-03-15 4:44 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
9,317 | $86.77 | $808,436 | 32,196 (Direct) |
View |
| 2023-03-10 Sale |
2023-03-13 5:23 pm |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
5,740 | $83.73 | $480,610 | 7,071 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-09 4:47 pm |
REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs |
19,036 | $83.43 | $1,588,137 | 73,757 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 5:17 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
96,996 | $87.67 | $8,503,621 | 173,143 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-08 5:08 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
165 | $84.58 | $13,956 | 26,765 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-08 5:04 pm |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer |
621 | $84.57 | $52,518 | 84,606 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-08 5:01 pm |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President |
622 | $84.69 | $52,680 | 88,304 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-08 4:59 pm |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
414 | $84.46 | $34,966 | 48,092 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-08 4:56 pm |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
3,961 | $83.46 | $330,585 | 40,131 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 5:04 pm |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer |
93,922 | $86.72 | $8,145,224 | 322,471 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-06 4:51 pm |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
2,169 | $87.57 | $189,939 | 48,506 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-06 4:48 pm |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President |
3,587 | $87.97 | $315,548 | 88,926 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:44 pm |
REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs |
1,819 | $88.08 | $160,209 | 42,793 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:40 pm |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
27,813 | $85.13 | $2,367,716 | 69,092 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-06 4:31 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
820 | $87.47 | $71,725 | 26,930 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-06 4:28 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
2,166 | $88.25 | $191,148 | 48,509 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 5:09 pm |
REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer |
75,000 | $85.46 | $6,409,473 | 881,754 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-07 Option Award |
2023-06-09 4:38 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | Ryder Steven Director |
441 | $73.68 | 13,485 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:38 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ryder Steven Director |
2,029 | $93.61 | 13,485 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:38 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | Ryder Steven Director |
2,137 | $0 | 13,485 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:32 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
576 | $73.68 | 10,072 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:32 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
2,136 | $93.61 | 10,072 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:32 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
2,137 | $0 | 10,072 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:30 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
1,628 | $73.68 | 5,903 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:30 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
4,275 | $0 | 5,903 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:24 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director |
1,682 | $93.61 | 7,702 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:24 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director |
2,137 | $0 | 7,702 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:20 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
135 | $73.68 | 8,289 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:20 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
1,788 | $93.61 | 8,289 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:20 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
2,137 | $0 | 8,289 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:13 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
169 | $73.68 | 8,422 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:13 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
1,815 | $93.61 | 8,422 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:13 pm |
N/A 2033-06-07 |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
2,137 | $0 | 8,422 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 4:35 pm |
2023-05-05 2029-08-28 |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President |
50,000 | $0 | 188,304 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-13 5:23 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
199 | $27.32 | 7,071 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-13 5:23 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
5,740 | $0 | 7,071 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-13 5:23 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
5,541 | $34.76 | 7,071 (Direct) |
View |
| 2023-03-07 Exercise |
2023-03-09 4:47 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs |
15,000 | $27.32 | 73,757 (Direct) |
View |
| 2023-03-07 Exercise |
2023-03-09 4:47 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs |
15,000 | $0 | 73,757 (Direct) |
View |
| 2023-03-06 Conversion |
2023-03-08 5:17 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
90,000 | $0 | 173,143 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 5:17 pm |
N/A 2026-09-06 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
90,000 | $0 | 173,143 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 5:17 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
90,000 | $21.05 | 173,143 (Direct) |
View |
| 2023-03-03 Gift |
2023-03-07 4:37 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
33,217 | $0 | 2,926,776 (Indirect) |
View |
| 2023-03-02 Conversion |
2023-03-06 5:04 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer |
88,636 | $0 | 322,471 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 5:04 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer |
88,636 | $0 | 322,471 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 5:04 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer |
88,636 | $11 | 322,471 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 4:40 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
25,000 | $27.32 | 69,092 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 4:40 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
25,000 | $0 | 69,092 (Direct) |
View |
| 2023-03-01 Conversion |
2023-03-03 5:09 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer |
75,000 | $0 | 881,754 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 5:15 pm |
N/A 2032-05-20 |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
9,000 | $0 | 33,750 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-01 4:18 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer |
45,000 | $0 | 120,513 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-01 4:16 pm |
N/A 2032-03-16 |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President |
75,000 | $0 | 75,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 5:35 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer |
237,975 | $0 | 1,743,517 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 5:17 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO, CFO and President |
118,988 | $0 | 187,988 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 5:12 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
79,325 | $0 | 114,325 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 5:01 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer |
118,988 | $0 | 170,988 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:50 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs |
59,494 | $0 | 92,350 (Direct) |
View |